Presenters in this workshop will discuss uptake of two new vaccines, MCV4 and Tdap, the potential impact of MCV4 on meningococcal disease trends, and the dynamics of vaccine exemptions on pertussis disease clustering. These topics highlight efforts made to monitor vaccine uptake and impact in three states: Oregon, California, and Michigan.